12th September 2014

Diurnal announces £6m funding round

Diurnal announces £6m funding round

Cardiff-based Diurnal is a pharmaceutical company creating innovative, high-value hormone therapeutics and advanced treatment regimens of approved drugs.

Finance Wales has re-invested alongside IP Group as part of a £6 million investment round. The full £6 million fundraising will enable Diurnal to complete the Phase 3 programme for its lead product Chronocort® as well as to advance certain other pipeline programmes.

Click here to see more